------------------------------
OMB APPROVAL
------------------------------
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden
hours per response ........0.5
------------------------------
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(h) of the Investment Company Act of 1940
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b).
================================================================================
1. Name and Address of Reporting Person*
Lanasa, III Joseph A.
--------------------------------------------------------------------------------
(Last) (First) (Middle)
c/o Goldman, Sachs & Co.
85 Broad Street
--------------------------------------------------------------------------------
(Street)
New York New York 10004
--------------------------------------------------------------------------------
(City) (State) (Zip)
================================================================================
2. Issuer Name and Ticker or Trading Symbol
Genesis Health Ventures, Inc.
(GHVI)
================================================================================
3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary)
================================================================================
4. Statement for Month/Day/Year
March 25, 2003
================================================================================
5. If Amendment, Date of Original (Month/Day/Year)
================================================================================
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
[ X ] Director [ ] 10% Owner
[ ] Officer (give title below) [ ] Other (specify below)
-------------------------------------------
================================================================================
7. Individual or Joint/Group Filing (Check Applicable Line)
[ X ] Form filed by One Reporting Person
[ ] Form filed by More than One Reporting Person
================================================================================
====================================================================================================================================
Table I -- Non-Derivative Securities Acquired, Disposed of, |
or Beneficially Owned |
====================================================================================================================================
| | | | |5. |6. | |
| | | | 4. |Amount of |Owner- | |
| | | | Securities Acquired (A) or |Securities |ship | |
| |2A. |3. | Disposed of (D) |Beneficially |Form: |7. |
|2. |Deemed |Transaction| (Instr. 3, 4 and 5) |Owned |Direct |Nature of |
|Transaction |Execution |Code | -------------------------------|Following |(D) or |Indirect |
1. |Date |Date, if |(Instr. 8) | | (A) | |Reported |Indirect |Beneficial|
Title of Security |(Month/Day/ |any(Month/|-----------| Amount | or | Price |Transactions |(I) |Ownership |
(Instr. 3) |Year) |Day/Year) | Code | V | | (D) | |(Instr. 3 & 4)|(Instr.4)|(Instr. 4)|
-----------------------------------------------------------------------------------------------------------------------------------|
| | | | | | | | | | |
Common Stock | 03/25/03 | | S | | 1,000,000 | D | $15.00 | 5,220,613 | I | 01,02 |
====================================================================================================================================
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
4(b)(v).
FORM 4 (continued)
====================================================================================================================================
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned |
(e.g., puts, calls, warrants, options, convertible securities) |
====================================================================================================================================
| | | | | | | | |9. |10. | |
|2. | | | | | | | |Number |Owner-| |
|Con- | | | | | | | |of |ship | |
|ver- | |3A. | | | | | |Deriv- |of | |
|sion | |De- | |5. | |7. | |ative |Deriv-|11. |
|or | |emed| |Number of | |Title and Amount | |Secur- |ative |Nature|
|Exer- | |Exe-| |Derivative |6. |of Underlying |8. |ities |Secur-|of |
|cise | |cu- |4. |Securities |Date |Securities |Price |Bene- |ity: |In- |
|Price |3. |tion|Trans-|Acquired (A)|Exercisable and |(Instr. 3 and 4) |of |ficially |Direct|direct|
|of |Trans- |Date|action|or Disposed |Expiration Date |-----------------------|Deriv- |Owned |(D) or|Bene- |
1. |Der- |action |if |Code |of (D) |(Month/Day/Year) | |Amount |ative |Following|In- |ficial|
Title of |iva- |Date |any,|(Instr|(Instr. 3, |-----------------| |or |Secur- |Reported |direct|Owner-|
Derivative |tive |(Month/ |(MM/|8) |4 and 5) |Date |Expira- | |Number |ity |Trans- |(I) |ship |
Security |Secu- |Day/ |DD/ |------|------------|Exer- |tion | |of |(Instr. |action(s)|(Instr|(Instr|
(Instr. 3) |rity |Year) |YY) |Code|V| (A) | (D) |cisable |Date |Title |Shares |5) |(Instr.4)|4) |4) |
-----------------------------------------------------------------------------------------------------------------------------------|
Stock Option | | | | | | | | | | | | | | | |
(right to buy) |$16.80| | | | | | | Immed. |10/02/12|Common Stock | 2,500 | | 2,500 | 01,03|01,03 |
-----------------------------------------------------------------------------------------------------------------------------------|
Stock Option | | | | | | | | | | | | | | | |
(right to buy) |$20.33| | | | | | | Immed. |10/02/11|Common Stock | 25,000 | | 25,000 | 01,03|01,03 |
-----------------------------------------------------------------------------------------------------------------------------------|
Series A | | | | | | | | | | | | | | | |
Convertible | | | | | | | | | | | | | | | |
Preferred | | | | | | | | | | | | | | | |
Stock |$20.33| | | | | | | Immed. | 04 |Common Stock | 353,167 | | 71,799 | I |01,04 |
====================================================================================================================================
Explanation of Responses:
01: The Reporting Person is a managing director of Goldman, Sachs & Co.
("Goldman Sachs"). Goldman Sachs is an indirect wholly-owned subsidiary of The
Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims
beneficial ownership of the securities reported herein, except to the extent of
his pecuniary interest therein, if any.
02: Goldman Sachs beneficially owns directly and GS Group may be deemed to
beneficially own indirectly 5,220,613 shares of common stock of Genesis Health
Ventures, Inc.
03: These options were granted pursuant to the Genesis Health Ventures, Inc.
2001 Stock Option Plan to the Reporting Person. The Reporting Person has an
understanding with GS Group pursuant to which he holds such options for the
benefit of GS Group.
04: Goldman Sachs beneficially owns directly and GS Group may be deemed to
beneficially own indirectly 71,799 shares of Series A convertible preferred
stock of Genesis Health Ventures, Inc. ("Series A Preferred"). The conversion
rate is $20.33 of liquidation preference for each share of common stock. The
Series A Preferred has a liquidation preference of $42,600,000 and accrues
dividends at the annual rate of 6% payable in additional shares of Series A
Preferred. The Series A Preferred are subject to mandatory redemption on October
2, 2010.
By: s/ Roger S. Begelman March 27, 2003
--------------------------------------------- -----------------------
**Signature of Reporting Person Date
Attorney-in-fact
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedures.
Alternatively, this Form is permitted to be submitted to the
Commission in electronic format at the option of the reporting person
pursuant to Rule 101(b)(4) of Regulation S-T.